APA (7th ed.) Citation

MD, A., EA, M., M, T., AM, T., RJ, B., MA, G., . . . KK, H. (2019). SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Annals of surgical oncology, 26(11), 3510. https://doi.org/10.1245/s10434-019-07577-4

Chicago Style (17th ed.) Citation

MD, Alvarado, et al. "SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer." Annals of Surgical Oncology 26, no. 11 (2019): 3510. https://doi.org/10.1245/s10434-019-07577-4.

MLA (9th ed.) Citation

MD, Alvarado, et al. "SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer." Annals of Surgical Oncology, vol. 26, no. 11, 2019, p. 3510, https://doi.org/10.1245/s10434-019-07577-4.